opioid addiction

The virtual opioid use disorder company reached profitability in Q4 2024, and expanded its team with the appointments of a chief operating officer and chief financial officer.

The telehealth company's providers can prescribe buprenorphine injections that patients can receive at Albertsons pharmacies, including Safeway and Acme.

Quit Genius, a digital addiction-recovery program, has extended its platform to support alcohol and opioid addictions.

The company's new 250 cart connects providers to specialists anywhere, not just within their own system.

The eight devices will receive increased guidance and interaction for their clearance efforts, and some will receive Breakthrough Device designation.

The app offers users a stronger recovery support network while helping care teams track and flag those at risk for relapse.

The US’s struggle with opioid addiction rages on, and Facebook seems to have heard critics’ warnings about social media’s role in the epidemic.

DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal.